Innovative Drug Discovery and Development
Formerly the John S. Dunn Gulf Coast Consortium for Chemical Genomics (GCC CG) which was formed in 2003, the Consortium for Innovative Drug Discovery and Development (GCC IDDD) is a research consortium focused on providing support for Houston/Galveston scientists in advancing their therapeutics discoveries through development to the clinic. IDDD support includes collaborative networking and joint funding opportunities, shared core resources, and educational programs.
Texas is “Going Big” in Biopharma
The Lone Star State is a rapidly emerging biopharma hub, with more than just a lone focus on oncology. Houston and Austin are home to some of the top up-and-coming biopharma companies, and real estate powerhouses like Hines are anchoring major new developments with them.
A COVID-19 Collaboration as Big as Texas
Drug discovery researchers from El Paso to Galveston join forces to find new therapeutics to combat the pandemic.
Artificial Intelligence Shakes Up Drug Discovery
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.
Please save the date for this exciting conference and stay tuned for speaker updates. James Inglese, NIH/NCATS is confirmed. More information can be found on the conference website.Find out more »